SANUWAVE Health, Inc. Cash Flow Statement
SNWV|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$432,000
FY2025
Free Cash Flow
-$58,000
FY2025
Capital Expenditures
$490,000
Cash used for long-term assets
Dividends Paid
N/A
FY2025
SANUWAVE Health, Inc. generated $432,000 in operating cash flow and negative free cash flow of $58,000 in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.4M | -$25.8M | -$10.3M | -$27.3M | -$30.9M | -$10.4M | -$11.6M | -$5.5M | -$6.4M | -$4.8M | -$6.0M | -$11.3M | -$6.4M | -$10.2M | -$14.9M |
| Depreciation & Amortization | $788.0K | $1.0M | $952.0K | $1.2M | $299.0K | $71.2K | $22.3K | $24.1K | $19.9K | $3.6K | $14.3K | $19.6K | $20.4K | $19.0K | $829.6K |
| Operating Cash Flow | $432.0K | -$4.5M | -$17.2M | -$6.4M | -$12.7M | -$6.4M | -$3.6M | -$1.5M | -$3.2M | -$3.5M | -$6.7M | -$3.9M | -$4.3M | -$8.8M | -$5.9M |
| Capital Expenditures | $490.0K | $0 | - | - | $53.0K | $53.9K | $42.9K | $0 | $10.4K | $10.4K | $8.9K | $8.9K | $2.0K | $42.3K | $42.3K |
| Free Cash Flow | -$58.0K | -$4.5M | - | - | -$12.8M | -$6.5M | -$3.7M | -$1.5M | -$3.2M | -$3.5M | -$6.7M | -$3.9M | -$4.3M | -$8.9M | -$5.9M |
| FCF Margin | -0.2% | -22.3% | - | - | -314.8% | -628.4% | -198.0% | -207.0% | -233.3% | -360.8% | -789.2% | -491.6% | -558.0% | -1105.7% | -811.3% |